• Profile
Close

Rivaroxaban, a direct factor Xa inhibitor, ameliorates hypertensive renal damage through inhibition of the inflammatory response mediated by protease-activated receptor pathway

Journal of the American Heart Association Apr 11, 2019

Ichikawa H, et al. - In hypertensive mice overexpressing renin (Ren-TG), researchers studied the impacts of rivaroxaban (factor Xa inhibitor) on hypertensive renal damage. Via oral route, Ren-TG and wild-type mice (12- to 16-week-old) were administered with or without 6 or 12 mg/kg of rivaroxaban for 1 or 4 months. In the Ren-TG vs in the wild-type mice, a significantly increased plasma factor Xa was seen that was reduced by 12 mg/kg of rivaroxaban. Compared with the wild-type mice, the nontreated 8-month-old Ren-TG had higher urinary albumin excretion (UAE). UAE was reduced to 38.1±13.2 μg/day by treatment with 12 mg/kg of rivaroxaban for 4 months. Overall, the protective impacts of rivaroxaban against angiotensin II–induced renal damage were suggested, which were partly via inhibition of the PAR (protease-activated receptors)-2 signaling-mediated inflammatory response.
Full text available Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay